US Stock MarketDetailed Quotes

AEON AEON Biopharma

Watchlist

1.340
-0.210-13.55%

Close Jun 18 16:00 ET

1.410
+0.070+5.22%

Post 18:31 ET

52.42MMarket Cap-129P/E (TTM)

AEON Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

22.23%-8.6M

-11.06M

-25.15%-35.58M

-8.45M

-200.53%-28.43M

78.85%-9.46M

-44.73M

Net income from continuing operations

-569.07%-118.02M

---17.64M

5.54%-52.56M

---34.56M

-69.04%-55.64M

-120.53%-32.91M

--160.32M

Operating gains losses

--43.82M

----

104.31%11.24M

---260.84M

Depreciation and amortization

0.00%25K

--25K

2,166.67%68K

--32K

--3K

--0

--1.26M

Deferred tax

----

--0

---14.65M

Other non cash items

1,271.18%63.86M

--4.66M

-76.26%4.41M

--19.67M

238.99%18.59M

-63.34%5.48M

--14.96M

Change In working capital

-82.19%96K

--539K

342.66%6.27M

--4.74M

-2.48%1.42M

2,804.00%1.45M

--50K

-Change in receivables

----

-593.33%-148K

--30K

-Change in inventory

----

--0

---7.39M

-Change in prepaid assets

217.95%124K

--39K

-136.26%-66K

---51K

555.00%182K

97.84%-40K

---1.86M

-Change in payables and accrued expense

-120.00%-92K

--460K

416.51%6.51M

--4.79M

-23.17%1.26M

-82.90%1.64M

--9.59M

-Change in other current liabilities

----

--0

---323K

-Change in other working capital

60.00%64K

--40K

-569.23%-174K

---5K

---26K

----

Cash from discontinued investing activities

Operating cash flow

22.23%-8.6M

---11.06M

-25.15%-35.58M

---8.45M

-200.53%-28.43M

78.85%-9.46M

---44.73M

Investing cash flow

Cash flow from continuing investing activities

-80.00%-306K

-9K

86.56%-170K

98.92%-1.27M

-117.29M

Capital expenditure reported

----

--0

---1.69M

Net PPE purchase and sale

----

-80.00%-306K

---9K

---170K

----

Net business purchase and sale

----

96.54%-1.27M

---36.53M

Net investment purchase and sale

----

--0

---79.07M

Cash from discontinued investing activities

Investing cash flow

--0

-80.00%-306K

---9K

86.56%-170K

98.92%-1.27M

---117.29M

Financing cash flow

Cash flow from continuing financing activities

-16.67%5M

198.67%40.51M

-3.99M

-44.80%13.56M

-66.44%24.57M

73.21M

Net issuance payments of debt

-16.67%5M

--6M

170.05%40.51M

---3.99M

-40.27%15M

159.46%25.11M

--9.68M

Net common stock issuance

----

--0

--77.73M

Net other financing activities

----

-165.62%-1.44M

96.19%-541K

---14.2M

Cash from discontinued financing activities

Financing cash flow

-16.67%5M

--6M

198.67%40.51M

---3.99M

-44.80%13.56M

-66.44%24.57M

--73.21M

Net cash flow

Beginning cash position

-47.08%5.16M

--9.75M

-74.57%5.13M

--22.2M

218.91%20.17M

-93.35%6.32M

--95.13M

Current changes in cash

28.83%-3.6M

---5.06M

130.70%4.62M

---12.46M

-208.64%-15.04M

115.59%13.84M

---88.8M

End cash Position

-66.77%1.56M

--4.69M

90.05%9.75M

--9.75M

-74.57%5.13M

218.91%20.17M

--6.32M

Free cash flow

22.23%-8.6M

---11.06M

-25.48%-35.89M

---8.46M

-202.33%-28.6M

79.62%-9.46M

---46.42M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	22.23%-8.6M	-11.06M	-25.15%-35.58M	-8.45M	-200.53%-28.43M	78.85%-9.46M	-44.73M
Net income from continuing operations	-569.07%-118.02M	---17.64M	5.54%-52.56M	---34.56M	-69.04%-55.64M	-120.53%-32.91M	--160.32M
Operating gains losses	--43.82M	----	----	----	----	104.31%11.24M	---260.84M
Depreciation and amortization	0.00%25K	--25K	2,166.67%68K	--32K	--3K	--0	--1.26M
Deferred tax	----	----	----	----	----	--0	---14.65M
Other non cash items	1,271.18%63.86M	--4.66M	-76.26%4.41M	--19.67M	238.99%18.59M	-63.34%5.48M	--14.96M
Change In working capital	-82.19%96K	--539K	342.66%6.27M	--4.74M	-2.48%1.42M	2,804.00%1.45M	--50K
-Change in receivables	----	----	----	----	----	-593.33%-148K	--30K
-Change in inventory	----	----	----	----	----	--0	---7.39M
-Change in prepaid assets	217.95%124K	--39K	-136.26%-66K	---51K	555.00%182K	97.84%-40K	---1.86M
-Change in payables and accrued expense	-120.00%-92K	--460K	416.51%6.51M	--4.79M	-23.17%1.26M	-82.90%1.64M	--9.59M
-Change in other current liabilities	----	----	----	----	----	--0	---323K
-Change in other working capital	60.00%64K	--40K	-569.23%-174K	---5K	---26K	----	----
Cash from discontinued investing activities
Operating cash flow	22.23%-8.6M	---11.06M	-25.15%-35.58M	---8.45M	-200.53%-28.43M	78.85%-9.46M	---44.73M
Investing cash flow
Cash flow from continuing investing activities			-80.00%-306K	-9K	86.56%-170K	98.92%-1.27M	-117.29M
Capital expenditure reported	----	----	----	----	----	--0	---1.69M
Net PPE purchase and sale	----	----	-80.00%-306K	---9K	---170K	----	----
Net business purchase and sale	----	----	----	----	----	96.54%-1.27M	---36.53M
Net investment purchase and sale	----	----	----	----	----	--0	---79.07M
Cash from discontinued investing activities
Investing cash flow	--0	--0	-80.00%-306K	---9K	86.56%-170K	98.92%-1.27M	---117.29M
Financing cash flow
Cash flow from continuing financing activities	-16.67%5M	6M	198.67%40.51M	-3.99M	-44.80%13.56M	-66.44%24.57M	73.21M
Net issuance payments of debt	-16.67%5M	--6M	170.05%40.51M	---3.99M	-40.27%15M	159.46%25.11M	--9.68M
Net common stock issuance	----	----	----	----	----	--0	--77.73M
Net other financing activities	----	----	----	----	-165.62%-1.44M	96.19%-541K	---14.2M
Cash from discontinued financing activities
Financing cash flow	-16.67%5M	--6M	198.67%40.51M	---3.99M	-44.80%13.56M	-66.44%24.57M	--73.21M
Net cash flow
Beginning cash position	-47.08%5.16M	--9.75M	-74.57%5.13M	--22.2M	218.91%20.17M	-93.35%6.32M	--95.13M
Current changes in cash	28.83%-3.6M	---5.06M	130.70%4.62M	---12.46M	-208.64%-15.04M	115.59%13.84M	---88.8M
End cash Position	-66.77%1.56M	--4.69M	90.05%9.75M	--9.75M	-74.57%5.13M	218.91%20.17M	--6.32M
Free cash flow	22.23%-8.6M	---11.06M	-25.48%-35.89M	---8.46M	-202.33%-28.6M	79.62%-9.46M	---46.42M
Currency Unit	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	--	Unqualified Opinion	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall